Genomic Health, Inc. (Nasdaq:GHDX) reported financial results and business progress for the quarter ended June 30, 2011. Total revenue increased to $50.8 million in the second quarter of 2011, compared with $43.4 million in the second quarter of 2010. Product revenue was $50.5 million in the second quarter of 2011, an increase of 19 percent, compared with $42.5 million in the second quarter of 2010.
Read more at http://crwewallstreet.com/?p=20818
(GHDX, NHPR, OMER, CLNO, GLBS) Featured Stock by CRWEWallStreet.com
August 10th, 2011 at 05:54 pm